136
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Self-perceived affective, behavioral, and cognitive reactions associated with voice use in people with Parkinson’s disease: a pilot study

ORCID Icon, ORCID Icon, , ORCID Icon &
Pages 180-188 | Received 15 Nov 2021, Accepted 17 May 2022, Published online: 12 Jun 2022

References

  • Ramig LO, Fox C, Sapir S. Parkinson’s disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment. Semin Speech Lang. 2004;25(2):169–180.
  • Schalling E, Johansson K, Hartelius L. Speech and communication changes reported by people with Parkinson’s Disease. Folia Phoniatr Logop. 2017;69(3):131–141.
  • Brabenec L, Mekyska J, Galaz Z, et al. Speech disorders in Parkinson’s disease: early diagnostics and effects of medication and brain stimulation. J Neural Transm. 2017;124(3):303–334.
  • Magee M, Copland D, Vogel AP. Motor speech and non-motor language endophenotypes of Parkinson’s disease. Expert Rev Neurother. 2019;19(12):1191–1200.
  • Holmes RJ, Oates JM, Phyland DJ, et al. Voice characteristics in the progression of Parkinson’s disease. Int J Lang Commun Disord. 2000;35(3):407–418.
  • Miller N, Noble E, Jones D, et al. How do I sound to me? Perceived changes in communication in Parkinson’s disease. Clin Rehabil. 2008;22(1):14–22.
  • Whitehead B. The psychosocial impact of communication changes in people with Parkinson’s disease. Br J Neurosci Nurs. 2010;6(1):30–36.
  • Miller N, Noble E, Jones D, et al. Life with communication changes in Parkinson’s disease. Age Ageing. 2006;35(3):235–239.
  • Francis DO, Daniero JJ, Hovis KL, et al. Voice-related patient-reported outcome measures: a systematic review of instrument development and validation. J Speech Lang Hear Res. 2017;60(1):62–88.
  • Slavych B, Engelhoven A, Zraick R. Quality of life in person’s with voice disorders: a review of Patient-Reported outcome measures. Artic Int J Ther Rehabil. 2013;20(6):308–315.
  • Carding PN, Wilson JA, Mackenzie K, et al. Measuring voice outcomes: state of the science review. J Laryngol Otol. 2009;123(8):823–829.
  • World Health Organization. How to use the ICF: a practical manual for using the international classification of functioning, disability and health (ICF). Exposure draft for comment. Geneva (Switzerland): WHO; 2013.
  • World Health Organization. Towards a common language for functioning, disability and health ICF towards a common language for functioning, disability and health. Geneva (Switzerland): WHO; 2002.
  • Blake HL, McLeod S. The international classification of functioning, disability and health: considering individuals from a perspective of health and wellness. Perspect ASHA SIGs. 2018;3(17):69–77.
  • Atkinson-Clement C, Letanneux A, Baille G, et al. Psychosocial impact of dysarthria: the patient-reported outcome as part of the clinical management. Neurodegener Dis. 2019;19(1):12–21.
  • Cardoso R, Guimarães I, Santos H, et al. Psychosocial impact of Parkinson’s disease-associated dysarthria: cross-cultural adaptation and validation of the dysarthria impact profile into European Portuguese. Geriatr Gerontol Int. 2018;18(5):767–774.
  • Letanneux A, Walshe M, Viallet F, et al. The dysarthria impact profile: a preliminary french experience with Parkinson’s disease. Park Dis. 2013;2013:1–6.
  • Donovan NJ, Kendall DL, Young ME, et al. The communicative effectiveness survey: preliminary evidence of construct validity. Am J Speech Lang Pathol. 2008;17(4):335–347.
  • Baylor CR, Yorkston KM, Eadie T, et al. The communicative participation item bank (CPIB): item bank calibration and development of a disorder-generic short form. J Speech Lang Hear Res. 2013;56(4):1190–1208.
  • Guimaraes I, Cardoso R, Pinto S, et al. The psychometric properties of the voice handicap index in people with Parkinson’s disease. J Voice. 2017;31(2):258.e13–258.e18.
  • Furtado E, Silva L, Côrtes Gama AC, et al. Idiopathic Parkinson’s disease: vocal and quality of life analysis. Arq Neuropsiquiatr. 2012;70(9):674–679.
  • Tamplin J, Morris ME, Marigliani C, et al. ParkinSong: a controlled trial of singing-based therapy for Parkinson’s disease. Neurorehabil Neural Repair. 33(6):453–463.
  • Walshe M, Peach RK, Miller N. Dysarthria impact profile: development of a scale to measure psychosocial effects. Int J Lang Commun Disord. 2009;44(5):693–715.
  • Hustad CK. Optimizing communicative effectiveness: bringing it together. In: Yorkston K, Beukelman D, Strand EA, Bell KR, editors. Management of motor speech disorders in children & adults. Austin (TX): Pro-Ed; 1999. p. 483–542.
  • Baylor CR, Yorkston KM, Eadie TL, et al. Developing the communicative participation item bank: Rasch analysis results from a spasmodic dysphonia sample. J Speech Lang Hear Res. 2009;52(5):1302–1320.
  • Yorkston KM, Baylor CR, Dietz J, et al. Developing a scale of communicative participation: a cognitive interviewing study. Disabil Rehabil. 2008;30(6):425–433.
  • Ma EPM, Yiu EML. Voice activity and participation profile: assessing the impact of voice disorders on daily activities. J Speech Lang Hear Res. 2001;44(3):511–524.
  • Jacobson BH, Johnson A, Grywalski C, et al. The voice handicap index (VHI): development and validation. Am J Speech Lang Pathol. 1997;6(3):66–70.
  • Hogikyan ND, Sethuraman G. Validation of an instrument to measure voice-related quality of life (V-RQOL). J Voice. 1999;13(4):557–569.
  • Vanryckeghem M, Brutten GJ. The behavior assessment battery for adults who stutter. San Diego (CA): Plural Publishing; 2018.
  • Vanryckeghem M, Hoffman Ruddy B, Lehman J. Behavior assessment battery: a pilot study of the affective, behavioral, and cognitive correlates surrounding spasmodic dysphonia. J Voice. 2016;30(1):53–60.
  • Vanryckeghem M, Hoffman Ruddy B. A preliminary investigation of the affective, behavioral and cognitive variables associated with spasmodic dysphonia. J Commun Disord Deaf Stud Hear Aids. 2015;3(2):1000131.
  • Watts CR, Vanryckeghem M. Communication-related affective, behavioral, and cognitive reactions in speakers with spasmodic dysphonia. Laryngoscope Investig Otolaryngol. 2017;2(6):466–470.
  • Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess. 1994;6(4):284–290.
  • Johansson IL, Samuelsson C, Müller N. Patients’ and communication partners’ experiences of communicative changes in Parkinson’s disease. Disabil Rehabil. 2020;42(13):1835–1843.
  • Yorkston KM, Baylor CR, Britton D. Speech versus speaking: the experiences of people with Parkinson’s disease and implications for intervention. Am J Speech Lang Pathol. 2017;26(2S):561–568.
  • Dykstra AD, Adams SG, Jog M. Examining the relationship between speech intensity and self-rated communicative effectiveness in individuals with Parkinson’s disease and hypophonia. J Commun Disord. 2015;56:103–112.
  • Wolters EC. Variability in the clinical expression of Parkinson’s disease. J Neurol Sci. 2008;266(1–2):197–203.
  • Majdinasab F, Karkheiran S, Soltani M, et al. Relationship between voice and motor disabilities of Parkinson’s disease. J Voice. 2016;30(6):768.e17–768.e22.
  • Sapir S. Multiple factors are involved in the dysarthria associated with Parkinson’s disease: a review with implications for clinical practice and research. J Speech Lang Hear Res. 2014;57(4):1330–1343.
  • Friedman JH. Misperceptions and Parkinson’s disease. J Neurol Sci. 2017;374:42–46.
  • Kwan LC, Whitehill TL. Perception of speech by individuals with Parkinson’s disease: a review. Park Dis. 2011;2011:1–11.
  • Miller N. Communication changes in Parkinson’s disease. Pract Neurol. 2017;17(4):266–274.
  • Hintze JM, Ludlow CL, Bansberg SF, et al. Spasmodic dysphonia: a review. Part 1: pathogenic factors. Otolaryngol Head Neck Surg. 2017;157(4):551–557.
  • Ludlow CL, Loucks T. Stuttering: a dynamic motor control disorder. J Fluency Disord. 2003;28(4):273–295.
  • Silverman FH, Hummer K. Spastic dysphonia: a fluency disorder? J Fluen Disord. 1989;14(4):285–291.
  • Ludlow CL. Central nervous system control of voice and swallowing. J Clin Neurophsiol. 2015;32(4):294–303.
  • Cannito MP, Burch AR, Watts CR, et al. Disfluency in spasmodic dysphonia: a multivariate analysis. J Speech Lang Hear Res. 1997;40(3):627–641.
  • Sveinbjornsdottir S. The clinical symptoms of Parkinson’s disease. J Neurochem. 2016;139:318–324.
  • Benke T, Hohenstein C, Poewe W, et al. Repetitive speech phenomena in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2000;69(3):319–325.
  • Spurgeon L, Clarke CE, Sackley C. Subjective experiences of speech and language therapy in patients with Parkinson’s disease: a pilot study. Rehabil Res Pr. 2015;2015:1–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.